(Q51981236)

English

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

scientific article published in September 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

0 references

author name string

Haack M

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Hinze-Selch D

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Fenzel T

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Kraus T

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Kühn M

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Schuld A

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Pollmächer T

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Journal of Psychiatric Research

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

33

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

407-418

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

In VitroEffects of Lithium Chloride on TNFα and IL-6 Production by Monocytes from Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Serum cytokine concentrations in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cytokine production in drug-free and neuroleptic-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Blood levels of cytokines in elderly patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cytokine antagonists in aged subjects and their relation with cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The association of plasma IL-6 levels with functional disability in community-dwelling elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cellular immunity and the hypothalamic-pituitary axis in major affective disorder: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Schizophrenia and smoking: an epidemiological survey in a state hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Mechanisms of CNS response to systemic immune challenge: the febrile response

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Decreased interleukin-2 production in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The prevalence of infections in psychiatric institutes in Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cytokines and the nervous system. I: Expression and recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Aberrant interleukin-2 receptor-mediated blastoformation of peripheral blood lymphocytes in a severe major depressive episode

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Decreased interleukin-2 production in Korean schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Immunoendocrine aspects of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Increased serum interleukin-1-receptor-antagonist concentrations in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

In vivo immunomodulatory effects of clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Elevated circulating levels of IL-6 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Behavioral assessment of patients treated with alpha-interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Influence of host defense activation on sleep in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Smoking affects plasma-soluble interleukin-2 receptor levels in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The effects of prolonged lithium exposure on the immune system of normal control subjects: serial serum soluble interleukin-2 receptor and antithyroid antibody measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Anesthetic agents induce human mononuclear leucocytes to release cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Production of cytokines in acute schizophrenic psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Immunological dysfunction in schizophrenia: a systematic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cytokines and the nervous system II: Actions and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Monocyte cytokine production in an elderly population: effect of age and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The soluble interleukin-2 receptor: biology, function, and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

No evidence for autoimmunity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cytokine production and serum proteins in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Serum interleukin-6 in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Indicators of immune activation in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The macrophage theory of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cytokines and pulmonary host defenses.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cigarette smoking influences cytokine production and antioxidant defences

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Benzodiazepine anesthesia in humans modulates the interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6 responses of blood monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Racial variation in serum-soluble interleukin-2 receptor levels: a population-based study of healthy smokers and nonsmokers

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Regulation of the HPA axis by cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Increase of plasma IL-6 concentration with age in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Cytokine production in major depressed patients before and after clomipramine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

Effects of granulocyte colony-stimulating factor on night sleep in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2899%2900021-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3956(99)00021-7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10504009

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51981236&oldid=1391045236"